Innate Pharma (IPHA) Asset Utilization Ratio (2022 - 2024)

Innate Pharma has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.83 in Q4 2024.

• For the quarter ending Q4 2024, Asset Utilization Ratio fell 7.47% year-over-year to 0.83; the trailing twelve-month figure through Dec 2024 stood at 0.83 (down 7.47% YoY), and the FY2025 full-year result was 0.03, down 75.82% from the prior year.
• Asset Utilization Ratio for Q4 2024 stood at 0.83, down from 0.92 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.92 in Q2 2024, with the low at 0.05 in Q2 2022.
• Historically, Asset Utilization Ratio has averaged 0.72 across 3 years, with a median of 0.9 in 2023.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio jumped 1800.57% — and 2024, when it fell 7.47%.
• Innate Pharma's Asset Utilization Ratio stood at 0.05 in 2022, then jumped by 1795.11% to 0.9 in 2023, then slipped by 7.47% to 0.83 in 2024.
• The last three Asset Utilization Ratio figures came in at 0.83 (Q4 2024), 0.92 (Q2 2024), and 0.9 (Q4 2023), per Business Quant data.